- Submitterʼs details
- This submission has been made anonymously
About the submission
- Is your organisation an Approved Sponsor for any of the following programs?
- Temporary Work (Skilled) (Subclass 457) visa program
- Employer Nomination Scheme (Subclass 186) visa program
- Regional Sponsored Migration Scheme (Subclass 187) visa program
- Labour agreements
- Are you an Australian assessing authority for migration purposes?
- Please select the industry your submission is in relation to. If required, you may select multiple industries.
- Professional, Scientific and Technical
- Do you have a particular regional interest? If required, you may select multiple regions.
1. Do you consider that occupations need to be added to the Medium and Long-term Strategic Skills List (MLTSSL)?
What occupations should be added to the Medium and Long-term Strategic Skills List (MLTSSL)?
Please also include occupations that you propose should be moved from the Short-term Skilled Occupation List (STSOL) to the MLTSSL.
- 224213 Health Information Manager
- 234511 Life Scientist (General)
- 132511 Research and Development Manager
Please outline the evidence or data that would support these occupations being added to the MLTSSL.
- The global industry of clinical research and development, currently contributes over AUD$1.1 billion to the Australian economy (https://www.mtpconnect.org.au/clinicaltrials: MTP Connect report July 2017).
Australia is home to a number of reputable organisations (>18) carrying out the more than 1,360 new clinical trials started in Australia each year (2015 figures) by both local and global pharmaceutical, biotech and medical device companies (see same report: ' Clinical Trials in Australia: the economic profile and competitive position of the sector'). The Australian clinical trial sector has been growing at roughly 5% per year since 2010, outpacing the US, the UK, and the overall global average growth rate.
The annual Scientific American Worldview Scorecard report consistently ranks Australia in the top 5 in terms of biotechnology activity, education of its workforce, stability of government and number of companies on the stock market.
Health and medical research is one of the strongest research disciplines in Australia, with over 60 per cent of research outputs ranked as ‘above’ or ‘well above world standard’ and medical research responsible for a quarter of all patents granted and almost half of all research commercialisation income achieved in 2015-16.
The Australian clinical trials sector supported at least 6,900 high skilled jobs in 2015, the large majority requiring tertiary education levels.
A recent survey by the Australian Regulatory and Clinical Scientist’s (ARCS), the leading industry body, shows that we will need to engage, train and employ a further 330 Clinical Research Associate (CRA) and Project Manager (PM) roles to grow and sustain the industry well into the future.
If Australia can maintain its historical growth in trial numbers and improve patient recruitment by 25%-50% on average across trials, the value of the sector could increase to approximately $2.1-2.5 billion and sector employment could increase to approximately 13-16,000 by 2025.
2. Do you consider that occupations need to be added to the Short Term Skilled Occupation List (STSOL)?
3. Do you consider that occupations need to be removed from the Medium and Long Term Strategic Skills List (MLTSSSL) or the Short Term Skilled Occupation List (STSOL)?
- Do you have any supporting material for your submission?
- Yes (see attachments)
If you have trouble accessing this document, please contact the Department to request a copy in a format you can use.